Christopher Schelling

Acer Therapeutics, Inc. develops therapeutics for the treatment of orphan diseases. Its current pipeline consists of two late-stage clinical products: ACER-002 for vascular Ehlers-Danlos Syndrome (vEDS), and ACER-001 for Maple Syrup Urine Disease (MSUD). The company was founded by Chris Schelling and is headquartered in Cambridge, MA.

Censa Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes therapeutics for orphan central nervous system disorders. The company was founded by Christopher Schelling in 2015 and is headquartered in Wellesley, MA.

Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX.

Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA.

Apanii Consulting LLC provides pharmaceutical and biotechnology consulting services. The private company is based in Bend, OR. The company was founded by Christopher Schelling.

Cascade Prodrug, Inc. engages is the research and development of targeted prodrug therapies. It provides technology for the treatment of hyper-proliferative diseases. The company was founded by August J. Sick and Allan Cochrane and is headquartered in Eugene, OR.